The sale caps a difficult time for zilovertamab and ONCT-808 under Oncternal’s ownership. Zilovertamab was deprioritised by ...

AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...

The FDA has approved Takeda’s new immunoglobulin therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat ...

Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some experts.

Vetter Pharma, has begun the construction of a new clinical manufacturing facility in Des Plaines, Illinois, US.

Torrent has signed definitive agreements to acquire stake in JB Pharma at an equity valuation of Rs256.89bn ($3bn) on a fully ...

As the pharma sector braces for sector-specific tariffs from President Trump, what could the impact look like on supply ...

The chronic kidney disease (CKD) anemia market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, ...

Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 ...

While the UK continues its close 25-year partnership with Gavi, the US is halting funding to the organisation. In a move that ...

Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the development capabilities for CAR T-cell therapies.

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...